Advertisement

Candidate Tumor Suppressor Gene EAF2 is Mutated in Colorectal and Gastric Cancers

  • Yun Sol Jo
  • Sung Soo Kim
  • Min Sung Kim
  • Nam Jin Yoo
  • Sug Hyung Lee
Letter to the Editor
  • 25 Downloads

Notes

Acknowledgements

This work was supported by a grant from National Research Foundation of Korea (2012R1A5A2047939).

Compliance with Ethical Standards

Conflict of Interest

The authors declare no competing interests.

References

  1. 1.
    Simone F, Luo RT, Polak PE, Kaberlein JJ, Thirman MJ (2003) ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood 101:2355–2362CrossRefPubMedGoogle Scholar
  2. 2.
    Xiao W, Zhang Q, Jiang F, Pins M, Kozlowski JM, Wang Z (2003) Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. Cancer Res 63:4698–4704PubMedGoogle Scholar
  3. 3.
    Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29:673–680CrossRefPubMedGoogle Scholar
  4. 4.
    Oh HR, An CH, Yoo NJ, Lee SH (2015) Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers. Pathol Oncol Res 21:713–718CrossRefPubMedGoogle Scholar
  5. 5.
    Liu JX, Zhang D, Xie X, Ouyang G, Liu X, Sun Y, Xiao W (2013) Eaf1 and Eaf2 negatively regulate canonical Wnt/β-catenin signaling. Development 140:1067–1078CrossRefPubMedGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2018

Authors and Affiliations

  1. 1.Department of Pathology, College of MedicineThe Catholic University of KoreaSeoulSouth Korea
  2. 2.Department of Internal Medicine, College of MedicineThe Catholic University of KoreaSeoulSouth Korea

Personalised recommendations